Page last updated: 2024-09-03

n-acetylglucosaminono-1,5-lactone o-(phenylcarbamoyl)oxime and Diabetes Mellitus, Type 2

n-acetylglucosaminono-1,5-lactone o-(phenylcarbamoyl)oxime has been researched along with Diabetes Mellitus, Type 2 in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kang, Y; Kim, Y; Kwon, H; Park, J1

Other Studies

1 other study(ies) available for n-acetylglucosaminono-1,5-lactone o-(phenylcarbamoyl)oxime and Diabetes Mellitus, Type 2

ArticleYear
Proteomic analysis of O-GlcNAc modifications derived from streptozotocin and glucosamine induced beta-cell apoptosis.
    Journal of biochemistry and molecular biology, 2007, Nov-30, Volume: 40, Issue:6

    Topics: Acetylglucosamine; Animals; Apoptosis; Cell Line; Diabetes Mellitus, Type 2; Glucosamine; Glycosylation; Insulin; Insulin Secretion; Insulin-Secreting Cells; Models, Biological; Oximes; Phenylcarbamates; Proteomics; Proto-Oncogene Proteins c-akt; Rats; Signal Transduction; Streptozocin

2007